These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24510513)

  • 21. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-treatment late complications of nasopharyngeal carcinoma.
    Lee CC; Ho CY
    Eur Arch Otorhinolaryngol; 2012 Nov; 269(11):2401-9. PubMed ID: 22249834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: A machine learning and multi-variable modelling study.
    Abdollahi H; Mostafaei S; Cheraghi S; Shiri I; Rabi Mahdavi S; Kazemnejad A
    Phys Med; 2018 Jan; 45():192-197. PubMed ID: 29329660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy.
    Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
    Otol Neurotol; 2004 Mar; 25(2):168-73. PubMed ID: 15021778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).
    Jagdis A; Laskin J; Hao D; Hay J; Wu J; Ho C
    Am J Clin Oncol; 2014 Feb; 37(1):63-9. PubMed ID: 23111356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.
    Ho WK; Wei WI; Kwong DL; Sham JS; Tai PT; Yuen AP; Au DK
    Head Neck; 1999 Sep; 21(6):547-53. PubMed ID: 10449671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hearing loss in patients with nasopharyngeal carcinoma after chemotherapy and radiation.
    Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
    Kaohsiung J Med Sci; 2003 Apr; 19(4):163-9. PubMed ID: 12795345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.
    Nakahara S; Hanamoto A; Seo Y; Miyaguchi S; Yamamoto Y; Tomiyama Y; Yoshii T; Takenaka Y; Yoshioka Y; Isohashi F; Ogawa K; Inohara H
    Jpn J Clin Oncol; 2016 Oct; 46(10):903-910. PubMed ID: 27474126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.
    Xu T; Shen C; Ou X; He X; Ying H; Hu C
    Oncotarget; 2016 Apr; 7(15):21013-22. PubMed ID: 26942700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
    Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
    Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
    Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
    Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
    Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
    Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
    Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
    Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Chan SL; Ng LS; Goh X; Siow CH; Goh HL; Goh BC; Cheo T; Loh KS; Brunham LR
    Head Neck; 2018 Jul; 40(7):1425-1433. PubMed ID: 29451951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inner ear deficits in irradiated nasopharyngeal carcinoma survivors.
    Chi FH; Young YH
    Laryngoscope; 2015 Nov; 125(11):2565-71. PubMed ID: 25945470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
    Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
    Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.
    Cho TY; Cheng PW; Young YH
    Laryngoscope; 2016 Sep; 126(9):2016-21. PubMed ID: 26864918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.